India’s Drug Regulator Expedites Introduction of Advanced Therapeutics
In a recent move to bring advanced therapeutics to India, the Drug Controller General of India (DCGI), who heads the […]
Regulatory
AstraZeneca withdraws Covid-19 vaccine and admits to rare side effects
In May, AstraZeneca retracted the marketing authorization for its COVID-19 vaccine due to commercial reasons. This decision followed months after